Michael F Mahoney
Director; Director, Chairman, President & CEO · 6 filings · Latest: Aug 3, 2026
BOSTON SCIENTIFIC CORP
CVS HEALTH Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Aug 3, 2026 | Purchase | $48.33 | 186,240 | $9.0M | 1,590,024 | |
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Feb 16, 2026 | Option Exercise | $0.00 | 16,265 | — | 1,584,725 | |
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Feb 14, 2026 | Option Exercise | $0.00 | 16,524 | — | 1,576,450 | |
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Feb 13, 2026 | Option Exercise | $0.00 | 8,832 | — | 1,692,025 | |
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Feb 12, 2026 | Option Exercise | $0.00 | 13,704 | — | 1,425,439 | |
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Feb 2, 2026 | Sale | $93.49 | 160,901 | $15.0M | 1,411,735 | |
BSX | Michael F Mahoney | Director, Chairman, President & CEO | Feb 2, 2026 | Option Exercise | $25.78 | 95,754 | $2.5M | 1,572,636 | |
BSX | MICHAEL F MAHONEY | — | Feb 2, 2026 | Proposed Sale | $93.49 | 160,901 | $15.0M | — | |
BSX | MICHAEL F MAHONEY | — | Jun 2, 2025 | Proposed Sale | $103.69 | 164,443 | $17.1M | — | |
BSX | MICHAEL F MAHONEY | — | May 1, 2025 | Proposed Sale | $102.48 | 164,443 | $16.9M | — | |
BSX | MICHAEL F MAHONEY | — | Apr 1, 2025 | Proposed Sale | $100.01 | 164,442 | $16.4M | — | |
BSX | MICHAEL F MAHONEY | — | Nov 5, 2024 | Proposed Sale | $84.75 | 162,778 | $13.8M | — | |
BSX | MICHAEL F MAHONEY | — | Oct 7, 2024 | Proposed Sale | $84.63 | 162,777 | $13.8M | — | |
BSX | MICHAEL F MAHONEY | — | Sep 5, 2024 | Proposed Sale | $81.17 | 162,777 | $13.2M | — |